Warrant

Reviva Pharmaceuticals (RVPH) announced a $9 million public offering of 27 million shares/equivalents, plus Series E & F warrants, priced at $0.335 per share. Proceeds will fund R&D and corporate purposes. The Series E warrants expire in 5 years, Series F in 12 months, both exercisable at $0.335. Expected closing is around Sept. 22, 2025. The offering, led by A.G.P./Alliance Global Partners, may lead to shareholder dilution, with potential for 54 million additional warrant shares.

Pacific Bay Minerals is raising up to $2 million through a non-brokered private placement of 20 million units to fund the acquisition and exploration of the Pereira-Velho Gold Project in Brazil. Additionally, the company is seeking to extend the expiry of 7.3 million warrants and has appointed Elton Pereira as country manager for Brazil.